Who are 18F-metaFluorobenzylguanidine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): DEXTROAMPHETAMINE, Duloxetine (Cymbalta), Effexor® (Venlafaxine), sibutramine+ microcrystalline cellulose, Solriamfetol Oral Tablet [Sunosi], bupropion immediate release (IR).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/18f-metafluorobenzylguanidine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

18F-metaFluorobenzylguanidine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

18F-metaFluorobenzylguanidine (18F-metaFluorobenzylguanidine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

phase 2 Norepinephrine transporter Oncology Small molecule Live · refreshed every 30 min

Target snapshot

18F-metaFluorobenzylguanidine (18F-metaFluorobenzylguanidine) — Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC). 18F-metaFluorobenzylguanidine is a radiopharmaceutical that selectively accumulates in neuroendocrine tumors, allowing for targeted imaging and therapy.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
18F-metaFluorobenzylguanidine TARGET	18F-metaFluorobenzylguanidine	Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)	phase 2		Norepinephrine transporter
DEXTROAMPHETAMINE	DEXTROAMPHETAMINE		marketed	Central nervous system stimulant	Dopamine transporter (DAT), Norepinephrine transporter (NET)	1955-01-01
Duloxetine (Cymbalta)	Duloxetine (Cymbalta)	New York State Psychiatric Institute	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin transporter (SERT); Norepinephrine transporter (NET)
Effexor® (Venlafaxine)	Effexor® (Venlafaxine)	Wyeth is now a wholly owned subsidiary of Pfizer	marketed	Serotonin-norepinephrine reuptake inhibitor (SNRI)	Serotonin transporter (SERT); Norepinephrine transporter (NET)
sibutramine+ microcrystalline cellulose	sibutramine+ microcrystalline cellulose	Promomed, LLC	marketed	Sympathomimetic amine; appetite suppressant	Norepinephrine transporter (NET), serotonin transporter (SERT), dopamine transporter (DAT)
Solriamfetol Oral Tablet [Sunosi]	Solriamfetol Oral Tablet [Sunosi]	Rochester Center for Behavioral Medicine	marketed	Dopamine and norepinephrine reuptake inhibitor	Dopamine transporter (DAT) and norepinephrine transporter (NET)
bupropion immediate release (IR)	bupropion-immediate-release-ir	Pfizer	marketed	Norepinephrine-dopamine reuptake inhibitor	Dopamine transporter, Norepinephrine transporter

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2033-10-24 — DEXTROAMPHETAMINE · 9456993 · Formulation · US
2033-10-24 — DEXTROAMPHETAMINE · 9474722 · Formulation · US
2042-01-06 — DEXTROAMPHETAMINE · 11559501 · Formulation · US

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 18F-metaFluorobenzylguanidine — Competitive Intelligence Brief. https://druglandscape.com/ci/18f-metafluorobenzylguanidine. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab